143 related articles for article (PubMed ID: 34510430)
1. Therapy-refractory folliculitis decalvans treated with certolizumab pegol.
Hoy M; Böhm M
Int J Dermatol; 2022 Jan; 61(1):e26-e28. PubMed ID: 34510430
[No Abstract] [Full Text] [Related]
2. Successful Use of Certolizumab Pegol for Refractory Psoriatic Arthritis Triggered by COVID-19 Infection.
Ohmura SI; Homma Y; Hanai S; Miyamoto T
Intern Med; 2022 Feb; 61(3):433-438. PubMed ID: 34803106
[TBL] [Abstract][Full Text] [Related]
3. Successful Treatment with Fusidic Acid in a Patient with Folliculitis Decalvans.
Pimenta R; Borges-Costa J
Acta Dermatovenerol Croat; 2019 Mar; 27(1):49-50. PubMed ID: 31032795
[TBL] [Abstract][Full Text] [Related]
4. Generalized pustular psoriasis in pregnancy, successfully treated with certolizumab pegol.
Mizutani Y; Mizutani YH; Matsuyama K; Kawamura M; Fujii A; Shu E; Ohnishi H; Seishima M
J Dermatol; 2020 Jul; 47(7):e262-e263. PubMed ID: 32363682
[No Abstract] [Full Text] [Related]
5. A case of psoriatic alopecia secondary to certolizumab pegol: clinical and trichoscopic evaluation.
Lauro W; Picone V; Abategiovanni L; Vastarella M; Gallo L; Fabbrocini G; Megna M
Int J Dermatol; 2023 Feb; 62(2):e70-e72. PubMed ID: 35579302
[No Abstract] [Full Text] [Related]
6. Refractory folliculitis decalvans treated with adalimumab: A case series of 23 patients.
Iorizzo M; Starace M; Vano-Galvan S; Piraccini BM; Reygagne P; Rudnicka L; Silyuk T; Sinclair R; Tosti A
J Am Acad Dermatol; 2022 Sep; 87(3):666-669. PubMed ID: 35245565
[No Abstract] [Full Text] [Related]
7. A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.
Bosch PC
Eur Urol; 2018 Nov; 74(5):623-630. PubMed ID: 30072210
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy should be considered for the treatment of folliculitis decalvans.
Yang L; Chen J; Tong X; Gao L; Ding S; Guo A
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102356. PubMed ID: 34048971
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy for the treatment of folliculitis decalvans.
Castaño-Suárez E; Romero-Maté A; Arias-Palomo D; Borbujo J
Photodermatol Photoimmunol Photomed; 2012 Apr; 28(2):102-4. PubMed ID: 22409714
[TBL] [Abstract][Full Text] [Related]
10. Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases.
Deeks ED
BioDrugs; 2016 Dec; 30(6):607-617. PubMed ID: 27704400
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Tumour Necrosis Factor-α Antagonists for Folliculitis Decalvans: A Retrospective Case-series Pilot Study.
Dupont A; Eyraud A; Milpied B; De Bataille S; Cassassa E; Darrigade AS; Barnetche T; Doutre MS; Matard B; Beylot-Barry M; Seneschal J
Acta Derm Venereol; 2023 Mar; 103():adv3713. PubMed ID: 36987539
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of refractory folliculitis decalvans with secukinumab.
Ismail FF; Sinclair R
Australas J Dermatol; 2020 May; 61(2):165-166. PubMed ID: 31646619
[No Abstract] [Full Text] [Related]
13. Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical Trials.
Loftus EV; Colombel JF; Schreiber S; Randall CW; Regueiro M; Ali T; Arendt C; Coarse J; Spearman M; Kosutic G
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1753-1762. PubMed ID: 27464588
[TBL] [Abstract][Full Text] [Related]
14. [Dapsone treatment of folliculitis decalvans].
Paquet P; Piérard GE
Ann Dermatol Venereol; 2004 Feb; 131(2):195-7. PubMed ID: 15026749
[TBL] [Abstract][Full Text] [Related]
15. Aminolevulinic acid photodynamic therapy for folliculitis decalvans: A case report.
Lin X; Zhou S; Wang X; Zhu X
Dermatol Ther; 2020 May; 33(3):e13358. PubMed ID: 32233085
[TBL] [Abstract][Full Text] [Related]
16. Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.
Lee SD; Rubin DT; Sandborn WJ; Randall C; Younes Z; Schreiber S; Schwartz DA; Burakoff R; Binion D; Dassopoulos T; Arsenescu R; Gutierrez A; Scherl E; Kayhan C; Hasan I; Kosutic G; Spearman M; Sen D; Coarse J; Hanauer S
Inflamm Bowel Dis; 2016 Aug; 22(8):1870-80. PubMed ID: 27400222
[TBL] [Abstract][Full Text] [Related]
17. Reply: Treatment of folliculitis decalvans with photodynamic therapy.
Miguel-Gómez L; Vañó-Galván S; Pérez-García B
J Am Acad Dermatol; 2016 Apr; 74(4):e71. PubMed ID: 26979372
[No Abstract] [Full Text] [Related]
18. Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Keystone E; Heijde Dv; Mason D; Landewé R; Vollenhoven RV; Combe B; Emery P; Strand V; Mease P; Desai C; Pavelka K
Arthritis Rheum; 2008 Nov; 58(11):3319-29. PubMed ID: 18975346
[TBL] [Abstract][Full Text] [Related]
19. Folliculitis decalvans-like pustular plaques on the limbs sparing the scalp.
Yang A; Hannaford R; Kossard S
Australas J Dermatol; 2020 Feb; 61(1):54-56. PubMed ID: 31621894
[TBL] [Abstract][Full Text] [Related]
20. Refractory folliculitis decalvans treated with biologics: Case series in 4 situations.
Lobato-Berezo A; Pujol RM
Dermatol Ther; 2022 Oct; 35(10):e15778. PubMed ID: 35988046
[No Abstract] [Full Text] [Related]
[Next] [New Search]
